• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Dec31
Distribution Plan(EST)

Cash dividend 0.132 USD

Dec23
Distribution Plan(EST)

Cash dividend 0.132 USD

Distribution Plan(EST)

Cash dividend 0.132 USD

View More

Event Tracking

Dec26
Ex-dividend date for Eli Lilly's Q1 2026 dividend
19:30
Eli Lilly anticipates FDA approval for its oral obesity drug orforglipron in Q1 2026
19:30
Study shows users of GLP-1 weight loss drugs reduce grocery spending
17:55
Tianfeng Securities releases a research report analyzing the weight-loss market and noting Eli Lilly's competitive advantage
13:50
Lilly Enters into a $55 Million R&D Collaboration and Equity Investment with South Korea's ABL Bio
12:52
Eli Lilly Pays ABL Bio $55 Million as a Prepayment
10:18